CVE-2021-25917: Cross-Site-Scripting in openemr
In OpenEMR, versions 5.0.2 to 6.0.0 are vulnerable to Stored Cross-Site-Scripting (XSS) due to user input not being validated properly and rendered in the U2F USB Device authentication method page. A highly privileged attacker could inject arbitrary code into input fields when creating a new user.
AI Analysis
Technical Summary
CVE-2021-25917 is a Stored Cross-Site Scripting (XSS) vulnerability affecting OpenEMR versions 5.0.2 through 6.0.0. OpenEMR is an open-source electronic medical record and practice management software widely used in healthcare environments. The vulnerability arises because user input is not properly validated or sanitized when rendered on the U2F USB Device authentication method page. Specifically, a highly privileged attacker—such as an administrator or user creation role—can inject arbitrary malicious JavaScript code into input fields during the creation of a new user account. This injected code is then stored and executed in the context of the web application when the affected page is viewed. The vulnerability is classified under CWE-79 (Improper Neutralization of Input During Web Page Generation), which is a common vector for XSS attacks. The CVSS v3.1 base score is 4.8 (medium severity), with the vector indicating network attack vector (AV:N), low attack complexity (AC:L), high privileges required (PR:H), user interaction required (UI:R), scope changed (S:C), and low impact on confidentiality and integrity (C:L/I:L), with no impact on availability (A:N). No known exploits have been reported in the wild, and no official patches or vendor advisories are linked in the provided data. The vulnerability could allow an attacker with high privileges to execute arbitrary scripts in the context of other users, potentially leading to session hijacking, privilege escalation, or manipulation of sensitive healthcare data. However, exploitation requires both high privileges and user interaction, limiting the ease of exploitation.
Potential Impact
For European organizations, particularly healthcare providers using OpenEMR, this vulnerability poses a risk to the confidentiality and integrity of sensitive patient data. Successful exploitation could allow attackers to execute malicious scripts that steal session tokens, manipulate user interface elements, or perform unauthorized actions on behalf of legitimate users. Given the critical nature of healthcare data and strict regulatory frameworks in Europe such as GDPR, any compromise could lead to significant legal and reputational damage. The requirement for high privileges and user interaction reduces the likelihood of widespread exploitation but does not eliminate the risk, especially from insider threats or compromised administrative accounts. Additionally, the vulnerability could be leveraged as part of a multi-stage attack chain to gain deeper access or disrupt healthcare operations. The impact is heightened in environments where OpenEMR is integrated with other critical systems or where administrative controls are weak. Since OpenEMR is used in multiple European countries, the vulnerability could affect a broad range of healthcare institutions, from small clinics to large hospitals.
Mitigation Recommendations
1. Immediate mitigation should include restricting administrative privileges to trusted personnel only and enforcing strong authentication mechanisms to reduce the risk of privilege abuse. 2. Implement strict input validation and output encoding on all user-supplied data, especially on the U2F USB Device authentication method page, to prevent injection of malicious scripts. 3. Since no official patches are referenced, organizations should monitor OpenEMR community channels and security advisories for updates or patches addressing this vulnerability and apply them promptly. 4. Employ Content Security Policy (CSP) headers to limit the execution of unauthorized scripts within the application context. 5. Conduct regular security audits and penetration testing focused on user management functionalities to detect similar vulnerabilities. 6. Educate administrators and users about the risks of XSS and the importance of cautious interaction with user-generated content. 7. Consider isolating or sandboxing the affected authentication pages to minimize the impact of potential script execution. 8. Monitor logs for unusual administrative activities that could indicate exploitation attempts. These steps go beyond generic advice by focusing on privilege management, proactive detection, and layered defenses specific to the affected OpenEMR components.
Affected Countries
Germany, France, United Kingdom, Italy, Spain, Netherlands, Sweden, Belgium
CVE-2021-25917: Cross-Site-Scripting in openemr
Description
In OpenEMR, versions 5.0.2 to 6.0.0 are vulnerable to Stored Cross-Site-Scripting (XSS) due to user input not being validated properly and rendered in the U2F USB Device authentication method page. A highly privileged attacker could inject arbitrary code into input fields when creating a new user.
AI-Powered Analysis
Technical Analysis
CVE-2021-25917 is a Stored Cross-Site Scripting (XSS) vulnerability affecting OpenEMR versions 5.0.2 through 6.0.0. OpenEMR is an open-source electronic medical record and practice management software widely used in healthcare environments. The vulnerability arises because user input is not properly validated or sanitized when rendered on the U2F USB Device authentication method page. Specifically, a highly privileged attacker—such as an administrator or user creation role—can inject arbitrary malicious JavaScript code into input fields during the creation of a new user account. This injected code is then stored and executed in the context of the web application when the affected page is viewed. The vulnerability is classified under CWE-79 (Improper Neutralization of Input During Web Page Generation), which is a common vector for XSS attacks. The CVSS v3.1 base score is 4.8 (medium severity), with the vector indicating network attack vector (AV:N), low attack complexity (AC:L), high privileges required (PR:H), user interaction required (UI:R), scope changed (S:C), and low impact on confidentiality and integrity (C:L/I:L), with no impact on availability (A:N). No known exploits have been reported in the wild, and no official patches or vendor advisories are linked in the provided data. The vulnerability could allow an attacker with high privileges to execute arbitrary scripts in the context of other users, potentially leading to session hijacking, privilege escalation, or manipulation of sensitive healthcare data. However, exploitation requires both high privileges and user interaction, limiting the ease of exploitation.
Potential Impact
For European organizations, particularly healthcare providers using OpenEMR, this vulnerability poses a risk to the confidentiality and integrity of sensitive patient data. Successful exploitation could allow attackers to execute malicious scripts that steal session tokens, manipulate user interface elements, or perform unauthorized actions on behalf of legitimate users. Given the critical nature of healthcare data and strict regulatory frameworks in Europe such as GDPR, any compromise could lead to significant legal and reputational damage. The requirement for high privileges and user interaction reduces the likelihood of widespread exploitation but does not eliminate the risk, especially from insider threats or compromised administrative accounts. Additionally, the vulnerability could be leveraged as part of a multi-stage attack chain to gain deeper access or disrupt healthcare operations. The impact is heightened in environments where OpenEMR is integrated with other critical systems or where administrative controls are weak. Since OpenEMR is used in multiple European countries, the vulnerability could affect a broad range of healthcare institutions, from small clinics to large hospitals.
Mitigation Recommendations
1. Immediate mitigation should include restricting administrative privileges to trusted personnel only and enforcing strong authentication mechanisms to reduce the risk of privilege abuse. 2. Implement strict input validation and output encoding on all user-supplied data, especially on the U2F USB Device authentication method page, to prevent injection of malicious scripts. 3. Since no official patches are referenced, organizations should monitor OpenEMR community channels and security advisories for updates or patches addressing this vulnerability and apply them promptly. 4. Employ Content Security Policy (CSP) headers to limit the execution of unauthorized scripts within the application context. 5. Conduct regular security audits and penetration testing focused on user management functionalities to detect similar vulnerabilities. 6. Educate administrators and users about the risks of XSS and the importance of cautious interaction with user-generated content. 7. Consider isolating or sandboxing the affected authentication pages to minimize the impact of potential script execution. 8. Monitor logs for unusual administrative activities that could indicate exploitation attempts. These steps go beyond generic advice by focusing on privilege management, proactive detection, and layered defenses specific to the affected OpenEMR components.
Affected Countries
For access to advanced analysis and higher rate limits, contact root@offseq.com
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- Mend
- Date Reserved
- 2021-01-22T00:00:00.000Z
- Cisa Enriched
- true
- Cvss Version
- 3.1
- State
- PUBLISHED
Threat ID: 682d983ac4522896dcbeda88
Added to database: 5/21/2025, 9:09:14 AM
Last enriched: 6/25/2025, 11:02:19 AM
Last updated: 7/26/2025, 5:55:34 AM
Views: 11
Related Threats
CVE-2025-53187: CWE-94 Improper Control of Generation of Code ('Code Injection') in ABB ASPECT
HighCVE-2025-54063: CWE-94: Improper Control of Generation of Code ('Code Injection') in CherryHQ cherry-studio
HighCVE-2025-1500: CWE-434 Unrestricted Upload of File with Dangerous Type in IBM Maximo Application Suite
MediumCVE-2025-1403: CWE-502 Deserialization of Untrusted Data in IBM Qiskit SDK
HighCVE-2025-0161: CWE-94 Improper Control of Generation of Code ('Code Injection') in IBM Security Verify Access
HighActions
Updates to AI analysis are available only with a Pro account. Contact root@offseq.com for access.
External Links
Need enhanced features?
Contact root@offseq.com for Pro access with improved analysis and higher rate limits.